Evidence map›Paper›PMID 40588796›Full record

ArticleCancer control : journal of the Moffitt Cancer Center

Integrating Machine Learning for Early Mortality Prediction in Lung Adenosquamous Carcinoma: A Web-Based Prognostic Model.

Min Liang, Xiaocai Li, Shangyu Xie, Xiaoying Huang, Shifan Tan

Abstract read
In one paragraph

Article in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Min LiangDepartment of Respiratory and Critical Care Medicine, Maoming People's Hospital, Maoming, China.ORCID 0000-0002-6313-2022
Xiaocai LiDepartment of Respiratory and Critical Care Medicine, Maoming People's Hospital, Maoming, China.
Shangyu XieDepartment of Respiratory and Critical Care Medicine, Maoming People's Hospital, Maoming, China.
Xiaoying HuangDepartment of Respiratory and Critical Care Medicine, Maoming People's Hospital, Maoming, China.
Shifan TanDepartment of Respiratory and Critical Care Medicine, Maoming People's Hospital, Maoming, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IntroductionCombined with the characteristics of adenocarcinoma and squamous cell carcinoma, lung adenosquamous carcinoma (ASC) is an uncommon histological subtype of lung cancer with more aggressive biological behavior. This study aimed to quantify the 90-day mortality rate in patients with ASC, identify associated features, and develop a predictive machine learning model.MethodsThis retrospective study obtained data from the Surveillance, Epidemiology, and End Results (SEER) program database, covering the period from 2000 to 2018. Through univariate logistic regression and Lasso analyses, significant prognostic features were determined. We developed predictive models using XGBoost, logistic regression, and AJCC staging algorithms, assessing their performance via metrics such as the Area Under the Receiver Operating Characteristic Curve (AUC), Decision Curve Analysis (DCA), Kolmogorov-Smirnov (KS) statistic, and calibration plots. Restricted Cubic Splines (RCS) were employed to assess potential non-linear relationships between continuous features and survival outcomes.ResultsOur analysis of 2820 eligible patients identified 6 clinical features significantly affecting outcomes. The XGBoost model exhibited exceptional discriminatory power, with AUC scores of 0.97 in the training set and 0.84 in the validation set, surpassing other models in all datasets according to AUC, KS score, DCA, and calibration analyses. RCS analysis showed a non-linear association between tumor size and prognosis, with a cutoff size of 44 mm. Moreover, we integrated the model into a web-based platform to enhance its accessibility.ConclusionsWe present a novel machine learning model, supported by an easily accessible web-based platform, to guide personalized clinical decision-making and optimize treatment strategies for patients with ASC.

Indexed as

Carcinoma, AdenosquamousLung NeoplasmsMachine LearningAgedFemaleHumansInternetMaleMiddle AgedPrognosisRetrospective StudiesROC CurveSEER Programearly mortalitylung adenosquamous carcinomamachine learningprognostic biomarkerXGBoost

Identifiers

PMID40588796
PMCPMC12209574

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.